The other concern I have is with the CR. There are 1bn shares on issue meaning NOR can issue 250m more, 58m were issued in November so let's say 200m can be issued (after May).
Current best case with 1.5c raises $3m while 1c raises $2m. Maybe they can pump the SP to try and achieve better but with the current cash burn and lack of revenue, added to the FY2018 R&D rebate being largely used already doesn't help the company look healthy to prospective clients wanting security.
I imagine all investors, big or small are a bit nervous!
Add to My Watchlist
What is My Watchlist?
